The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly

Alzheimer's and Dementia

Volumn 9, Issue 6, 2013, Pages 687-698.e1

  Wirth, Miranka ^a   Oh, Hwamee ^a   Mormino, Elizabeth C ^a   Markley, Candace ^a   Landau, Susan M ^a,b   Jagust, William J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Alzheimer's disease; Amyloid; Cognitive aging; FDG; Glucose metabolism; Gray matter structure; Memory; PiB; Preclinical decline

Indexed keywords

AMYLOID BETA PROTEIN; PITTSBURGH COMPOUND B;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; EXECUTIVE FUNCTION; FEMALE; GENOTYPE; GERIATRIC DEPRESSION SCALE; GERIATRIC PATIENT; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; MEMORY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PRIORITY JOURNAL; SEMANTIC MEMORY; VISUAL MEMORY;

ALZHEIMER'S DISEASE; AMYLOID; COGNITIVE AGING; FDG; GLUCOSE METABOLISM; GRAY MATTER STRUCTURE; MEMORY; PIB; PRECLINICAL DECLINE;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; ANILINE COMPOUNDS; APOLIPOPROTEINS E; BRAIN; COGNITION DISORDERS; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; GENOTYPE; GERIATRIC ASSESSMENT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; REGRESSION ANALYSIS; THIAZOLES;

EID: 84887471492     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.10.012     Document Type: Article

References (58)

1. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, and M.W. Weiner Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
2. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, and A.M. Fagan Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
3. M.A. Mintun, G.N. Larossa, Y.I. Sheline, C.S. Dence, S.Y. Lee, and R.H. Mach [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease Neurology 67 2006 446 452
4. H. Quigley, S.J. Colloby, and J.T. O'Brien PET imaging of brain amyloid in dementia: a review Int J Geriatr Psychiatry 26 2011 991 999
5. W.E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, and D.P. Holt Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B Ann Neurol 55 2004 306 319
6. M. Storandt, M.A. Mintun, D. Head, and J.C. Morris Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition Arch Neurol 66 2009 1476 1481
7. S.M. Resnick, J. Sojkova, Y. Zhou, Y. An, W. Ye, and D.P. Holt Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB Neurology 74 2010 807 815
8. V.L. Villemagne, K.E. Pike, D. Darby, P. Maruff, G. Savage, and S. Ng Abeta deposits in older nondemented individuals with cognitive decline are indicative of preclinical Alzheimer's disease Neuropsychologia 46 2008 1688 1697
9. K.E. Pike, G. Savage, V.L. Villemagne, S. Ng, S.A. Moss, and P. Maruff Beta-amyloid imaging and memory in nondemented individuals: evidence for preclinical Alzheimer's disease Brain 130 2007 2837 2844
10. G. Chetelat, V.L. Villemagne, K.E. Pike, K.A. Ellis, P. Bourgeat, and G. Jones Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease Brain 134 2011 798 807
11. J.C. Morris, C.M. Roe, E.A. Grant, D. Head, M. Storandt, and A.M. Goate Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease Arch Neurol 66 2009 1469 1475
12. V.L. Villemagne, K.E. Pike, G. Chetelat, K.A. Ellis, R.S. Mulligan, and P. Bourgeat Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease Ann Neurol 69 2011 181 192
13. H.J. Aizenstein, R.D. Nebes, J.A. Saxton, J.C. Price, C.A. Mathis, and N.D. Tsopelas Frequent amyloid deposition without significant cognitive impairment among the elderly Arch Neurol 65 2008 1509 1517
14. H. Oh, E.C. Mormino, C. Madison, A. Hayenga, A. Smiljic, and W.J. Jagust Beta-amyloid affects frontal and posterior brain networks in normal aging Neuroimage 54 2011 1887 1895
15. E.C. Mormino, J.T. Kluth, C.M. Madison, G.D. Rabinovici, S.L. Baker, and B.L. Miller Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects Brain 132 2009 1310 1323
16. S.M. Landau, D. Harvey, C.M. Madison, R.A. Koeppe, E.M. Reiman, and N.L. Foster Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI Neurobiol Aging 32 2011 1207 1218
17. S.M. Landau, D. Harvey, C.M. Madison, E.M. Reiman, N.L. Foster, and P.S. Aisen Comparing predictors of conversion and decline in mild cognitive impairment Neurology 75 2010 230 238
18. W. Jagust, A. Gitcho, F. Sun, B. Kuczynski, D. Mungas, and M. Haan Brain imaging evidence of preclinical Alzheimer's disease in normal aging Ann Neurol 59 2006 673 681
19. M.J. de Leon, A. Convit, O.T. Wolf, C.Y. Tarshish, S. DeSanti, and H. Rusinek Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron emission tomography (FDG/PET) Proc Natl Acad Sci U S A 98 2001 10966 10971
20. R.S. Desikan, L.K. McEvoy, W.K. Thompson, D. Holland, J.C. Roddey, and K. Blennow Amyloid-beta associated volume loss occurs only in the presence of phospho-tau Ann Neurol 70 2011 657 661
21. D. Mungas, B.R. Reed, and J.H. Kramer Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons Neuropsychology 17 2003 380 392
22. L.R. Squire, and S.M. Zola Episodic memory, semantic memory, and amnesia Hippocampus 8 1998 205 211
23. H. Braak, E. Braak, and J. Bohl Staging of Alzheimer-related cortical destruction Eur Neurol 33 1993 403 408
24. E. Grober, C.B. Hall, R.B. Lipton, A.B. Zonderman, S.M. Resnick, and C. Kawas Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease J Int Neuropsychol Soc 14 2008 266 278
25. H. Amieva, L. Carcaillon, P. Rouze L'Alzit-Schuermans, X. Millet, J.F. Dartigues, and C. Fabrigoule [Cued and uncued memory tests: norms in elderly adults from the 3 Cities epidemiological study] Rev Neurol (Paris) 163 2007 205 221
26. D. Wechsler Wechsler Adult Intelligence Scale-III 1997 The Psychological Corporation San Antonio, TX
27. J.C. Price, W.E. Klunk, B.J. Lopresti, X. Lu, J.A. Hoge, and S.K. Ziolko Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-B J Cereb Blood Flow Metab 25 2005 1528 1547
28. B. Fischl, D.H. Salat, E. Busa, M. Albert, M. Dieterich, and C. Haselgrove Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain Neuron 33 2002 341 355
29. K.E. Pike, K.A. Ellis, V.L. Villemagne, N. Good, G. Chetelat, and D. Ames Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study Neuropsychologia 49 2011 2384 2390
30. E.C. Mormino, M.G. Brandel, C.M. Madison, G.D. Rabinovici, S. Marks, and S.L. Baker Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant Neuroimage 59 2012 1152 1160
31. S. Minoshima, K.A. Frey, N.L. Foster, and D.E. Kuhl Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis J Comput Assist Tomogr 19 1995 541 547
32. R.S. Desikan, F. Segonne, B. Fischl, B.T. Quinn, B.C. Dickerson, and D. Blacker An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest Neuroimage 31 2006 968 980
33. J. Cohen Applied multiple regression/correlation analysis for the behavioral sciences 3rd ed. 2003 L. Erlbaum Associates Mahwah, NJ
34. P.A. Frazier, A.P. Tix, and K.E. Barron Testing moderator and mediator effects in counseling psychology research J Couns Psychol 51 2004 115 134
35. A.P. Field Discovering statistics using SPSS: (and sex, drugs and rock' n' roll) 2nd ed. 2005 Sage Publications London
36. L.S. Aiken, and S.G. West Multiple regression: testing and interpreting interactions 1991 Sage Publications Newbury Park, CA
37. J. Cohen, P. Cohen, S.G. West, and L.S. Aiken Applied multiple regression/correlation analysis for the behavioral sciences 3rd ed. 2003 L. Erlbaum Associates Mahwah, NJ
38. R.D. Cook, and S. Weisberg Residuals and influence in regression 1982 Chapman and Hall New York
39. K.M. Rodrigue, K.M. Kennedy, M.D. Devous Sr., J.R. Rieck, A.C. Hebrank, and R. Diaz-Arrastia Beta-amyloid burden in healthy aging: regional distribution and cognitive consequences Neurology 78 2012 387 395
40. C.C. Rowe, K.A. Ellis, M. Rimajova, P. Bourgeat, K.E. Pike, and G. Jones Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging Neurobiol Aging 31 2010 1275 1283
41. C.R. Jack Jr., V.J. Lowe, M.L. Senjem, S.D. Weigand, B.J. Kemp, and M.M. Shiung 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment Brain 131 2008 665 680
42. A.D. Cohen, J.C. Price, L.A. Weissfeld, J. James, B.L. Rosario, and W. Bi Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve J Neurosci 29 2009 14770 14778
43. D.M. Rentz, J.J. Locascio, J.A. Becker, E.K. Moran, E. Eng, and R.L. Buckner Cognition, reserve, and amyloid deposition in normal aging Ann Neurol 67 2010 353 364
44. J.O. Goh, Y. An, and S.M. Resnick Differential trajectories of age-related changes in components of executive and memory processes Psychol Aging 27 2012 707 719
45. A. Drzezga, J.A. Becker, K.R. Van Dijk, A. Sreenivasan, T. Talukdar, and C. Sullivan Neuronal dysfunction and disconnection of cortical hubs in nondemented subjects with elevated amyloid burden Brain 134 2011 1635 1646
46. J.A. Becker, T. Hedden, J. Carmasin, J. Maye, D.M. Rentz, and D. Putcha Amyloid-beta associated cortical thinning in clinically normal elderly Ann Neurol 69 2011 1032 1042
47. C.R. Jack Jr., D.S. Knopman, S.D. Weigand, H.J. Wiste, P. Vemuri, and V. Lowe An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease Ann Neurol 71 2012 765 775
48. W.J. Jagust, and E.C. Mormino Lifespan brain activity, beta-amyloid, and Alzheimer's disease Trends Cogn Sci 15 2011 520 526
49. R.S. Desikan, L.K. McEvoy, W.K. Thompson, D. Holland, J.B. Brewer, and P.S. Aisen Amyloid-beta-associated clinical decline occurs only in the presence of elevated P-tau Arch Neurol 69 2012 709 713
50. J. Sojkova, Y. Zhou, Y. An, M.A. Kraut, L. Ferrucci, and D.F. Wong Longitudinal patterns of beta-amyloid deposition in nondemented older adults Arch Neurol 68 2011 644 649
51. J.A. Yesavage, T.L. Brink, T.L. Rose, O. Lum, V. Huang, and M. Adey Development and validation of a geriatric depression screening scale: a preliminary report J Psychiatric Res 17 1982 37 49
52. M. Folstein, S. Folstein, and P. McHugh "Mini-mental state": a practical method for grading the cognitive state of patients for the clinicians J Psychiatric Res 12 1975 189 198
53. nd ed. 2000 Psychological Corporation San Antonio, TX
54. D. Wechsler WMS-R: Wechsler Memory Scale-Revised: manual 1987 Psychological Corporation/Harcourt Brace Jovanovich San Antonio, TX
55. M.R. Trenerry, B. Crosson, J. DeBoe, and W.R. Leber The Stroop Neuropsychological Screening Test 1989 Neuropsychological Assessment Resources Odessa, FL
56. A.L. Benton, and K.D. Hamsher Multilingual aphasia examination 1989 AJA Associate Iowa City, IA
57. R.M. Reitan Validity of the trailmaking test as an indication of organic brain damage Percept Mot Skills 8 1955 271 276
58. J. Logan, J.S. Fowler, N.D. Volkow, G.J. Wang, Y.S. Ding, and D.L. Alexoff Distribution volume ratios without blood sampling from graphical analysis of PET data J Cereb Blood Flow Metab 16 1996 834 840